Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines
Miao Deng(Sichuan University), Dechun Liu(Henan University of Science and Technology), Like Zhang(Henan University of Science and Technology), Qipeng Liu(First Affiliated Hospital of Henan University of Science and Technology), Yanbin Chen, Pengfei Yuan(Hefei University of Technology), Jianguang Wang(Jiamusi University), Gangqiang Xie(Henan University of Science and Technology), Ting Zhang(First Affiliated Hospital of Henan University of Science and Technology)
Cited by 26
Related Papers
Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library
|Nature Biotechnology|2016|438
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
|Biomedicine & Pharmacotherapy|2019|200
Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
|Cancer Medicine|2019|197
Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B
|Cell Research|2014|174
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
|Journal of Controlled Release|2019|126